| Keith A Scott, MD | |
|
901 W Greenwood St, Suite 9, Abbeville, SC 29620-5717 | |
| (864) 366-9681 | |
| (864) 366-5600 |
| Full Name | Keith A Scott |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 901 W Greenwood St, Abbeville, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740280718 | NPI | - | NPPES |
| RHC210 | Medicaid | SC | |
| 21174 | Other | SC | SC LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 21174 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Health Related Home Care | Abbeville, SC | Home health agency |
| Hospice Care Of South Carolina | Spartanburg, SC | Hospice |
| Abbeville Area Medical Center | Abbeville, SC | Hospital |
| Self Regional Healthcare | Greenwood, SC | Hospital |
| Abbeville Nursing Home, Inc. | Abbeville, SC | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abbeville County Memorial Hospital | 7719891506 | 26 |
| Edcare Consulting Llc | 5193086833 | 16 |
News Archive
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
A new scoping review found that those with chronic health concerns, such as diabetes, heart disease, cancer, and autoimmune conditions, are not only at a higher risk of severe COVID-19 infection, they are also more likely to experience anxiety, depression or substance use during the COVID-19 pandemic.
Cervical cancer is highly curable when caught early. But in a third of cases, the tumor responds poorly to therapy or recurs later, when cure is much less likely.
A new paper to be published in The Journal of Shoulder and Elbow Surgery evaluates the effect that topical benzoyl peroxide (BPO), with chlorhexidine skin preparation, has on the presence of Propionibacterium acnes cultured at the time of shoulder surgery. The authors hypothesized that adding topical BPO, the active ingredient in Clearasil, to the pre-operative skin preparation would reduce the number of positive P. acnes cultures identified during surgery.
› Verified 1 days ago
| Entity Name | Abbeville County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649816216 PECOS PAC ID: 7719891506 Enrollment ID: O20031117000214 |
News Archive
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
A new scoping review found that those with chronic health concerns, such as diabetes, heart disease, cancer, and autoimmune conditions, are not only at a higher risk of severe COVID-19 infection, they are also more likely to experience anxiety, depression or substance use during the COVID-19 pandemic.
Cervical cancer is highly curable when caught early. But in a third of cases, the tumor responds poorly to therapy or recurs later, when cure is much less likely.
A new paper to be published in The Journal of Shoulder and Elbow Surgery evaluates the effect that topical benzoyl peroxide (BPO), with chlorhexidine skin preparation, has on the presence of Propionibacterium acnes cultured at the time of shoulder surgery. The authors hypothesized that adding topical BPO, the active ingredient in Clearasil, to the pre-operative skin preparation would reduce the number of positive P. acnes cultures identified during surgery.
› Verified 1 days ago
| Entity Name | Edcare Consulting Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053534750 PECOS PAC ID: 5193086833 Enrollment ID: O20180221000847 |
News Archive
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
A new scoping review found that those with chronic health concerns, such as diabetes, heart disease, cancer, and autoimmune conditions, are not only at a higher risk of severe COVID-19 infection, they are also more likely to experience anxiety, depression or substance use during the COVID-19 pandemic.
Cervical cancer is highly curable when caught early. But in a third of cases, the tumor responds poorly to therapy or recurs later, when cure is much less likely.
A new paper to be published in The Journal of Shoulder and Elbow Surgery evaluates the effect that topical benzoyl peroxide (BPO), with chlorhexidine skin preparation, has on the presence of Propionibacterium acnes cultured at the time of shoulder surgery. The authors hypothesized that adding topical BPO, the active ingredient in Clearasil, to the pre-operative skin preparation would reduce the number of positive P. acnes cultures identified during surgery.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keith A Scott, MD Po Box 968, Abbeville, SC 29620-0968 Ph: (864) 366-9681 | Keith A Scott, MD 901 W Greenwood St, Suite 9, Abbeville, SC 29620-5717 Ph: (864) 366-9681 |
News Archive
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
A new scoping review found that those with chronic health concerns, such as diabetes, heart disease, cancer, and autoimmune conditions, are not only at a higher risk of severe COVID-19 infection, they are also more likely to experience anxiety, depression or substance use during the COVID-19 pandemic.
Cervical cancer is highly curable when caught early. But in a third of cases, the tumor responds poorly to therapy or recurs later, when cure is much less likely.
A new paper to be published in The Journal of Shoulder and Elbow Surgery evaluates the effect that topical benzoyl peroxide (BPO), with chlorhexidine skin preparation, has on the presence of Propionibacterium acnes cultured at the time of shoulder surgery. The authors hypothesized that adding topical BPO, the active ingredient in Clearasil, to the pre-operative skin preparation would reduce the number of positive P. acnes cultures identified during surgery.
› Verified 1 days ago
Mr. Charles A. Kolb, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 W Greenwood St, Suite 9, Abbeville, SC 29620 Phone: 864-366-9681 Fax: 864-366-5600 | |
Dr. Steven D. Adams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 420 Thomson Cir, Abbeville, SC 29620 Phone: 864-366-5011 Fax: 864-366-3343 | |
Dr. Bruce Samuel Johnston, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 901 W Greenwood St, Suite 9, Abbeville, SC 29620 Phone: 864-366-9681 Fax: 864-366-5600 | |
Ashley Elizabeth Harte, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 901 W Greenwood St, Suite 9, Abbeville, SC 29620 Phone: 864-366-9681 Fax: 864-366-5600 | |
Dr. Christopher Lee Oxendine, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 W Greenwood St, Suite 9, Abbeville, SC 29620 Phone: 864-366-9681 Fax: 864-366-5600 | |
Bridgett Heather Seagroves, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1822 Monterey Rd, Abbeville, SC 29620 Phone: 615-335-4666 Fax: 864-330-1864 | |
Douglas Boylston Moore Iii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 W Greenwood St, Suite 9, Abbeville, SC 29620 Phone: 864-366-9681 Fax: 864-366-5600 |